Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Evaluation of the role of TAX, HBZ, and HTLV-1 proviral load on the survival of ATLL patients

´ëÇÑÇ÷¾×ÇÐȸÁö 2017³â 52±Ç 2È£ p.106 ~ 111
Akbarin Mohammad Mehdi, Shirdel Abbas, Bari Alireza, Mohaddes Seyedeh Tahereh, Rafatpanah Houshang, Karimani Ehsan Ghayour, Etminani Kobra, Golabpour Amin, Torshizi Reza,
¼Ò¼Ó »ó¼¼Á¤º¸
 ( Akbarin Mohammad Mehdi ) 
Mashhad University of Medical Sciences Faculty of Medicine Inflammation and Inflammatory Diseases Research Center

 ( Shirdel Abbas ) 
Mashhad University of Medical Sciences Faculty of Medicine Ghaem Hospital Department of Hematology
 ( Bari Alireza ) 
Mashhad University of Medical Sciences Faculty of Medicine Ghaem Hospital Department of Hematology
 ( Mohaddes Seyedeh Tahereh ) 
Mashhad University of Medical Sciences Faculty of Medicine Ghaem Hospital Department of Hematology
 ( Rafatpanah Houshang ) 
Mashhad University of Medical Sciences Faculty of Medicine Inflammation and Inflammatory Diseases Research Center
 ( Karimani Ehsan Ghayour ) 
Razavi Hospital Department of Research and Education Molecular Diagnostic Unit
 ( Etminani Kobra ) 
Mashhad University of Medical Sciences Faculty of Medicine Department of Medical Informatics
 ( Golabpour Amin ) 
Mashhad University of Medical Sciences Faculty of Medicine Department of Medical Informatics
 ( Torshizi Reza ) 
Mashhad University of Medical Sciences Faculty of Medicine Department of Modern Sciences and Technologies

Abstract


Background: Adult T-cell leukemia/lymphoma (ATLL) is an aggressive malignancy with very poor prognosis and short survival, caused by the human T-lymphotropic virus type-1 (HTLV-1). The HTLV-1 biomarkers trans-activator x (TAX) and HTLV-1 basic leucine zipper factor (HBZ) are main oncogenes and life-threatening elements. This study aimed to assess the role of the TAX and HBZ genes and HTLV-1 proviral load (PVL) in the survival of patients with ATLL.

Methods: Forty-three HTLV-1-infected individuals, including 18 asymptomatic carriers (AC) and 25 ATLL patients (ATLL), were evaluated between 2011 and 2015. The mRNA expression of TAX and HBZ and the HTLV-1 PVL were measured by quantitative PCR.

Results: Significant differences in the mean expression levels of TAX and HBZ were observed between the two study groups (ATLL and AC, P =0.014 and P=0.000, respectively). In addition, the ATLL group showed a significantly higher PVL than AC (P=0.000). There was a significant negative relationship between PVL and survival among all study groups (P =0.047).

Conclusion: The HTLV-1 PVL and expression of TAX and HBZ were higher in the ATLL group than in the AC group. Moreover, a higher PVL was associated with shorter survival time among all ATLL subjects. Therefore, measurement of PVL, TAX, and HBZ may be beneficial for monitoring and predicting HTLV-1-infection outcomes, and PVL may be useful for prognosis assessment of ATLL patients. This research demonstrates the possible correlation between these virological markers and survival in ATLL patients.

Å°¿öµå

HTLV-1; ATLL; TAX; HBZ; Proviral load

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS